Clinical Trial Update: GEN1047 for Solid Tumors - First in Human (FIH) Trial [Phase 1, Phase 2]

View source ↗

Summary

Genmab's GEN1047 first-in-human Phase 1/2 trial in solid tumors has been terminated, with indications including breast cancer, endometrial cancer, ovarian cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• GEN1047

Snippet

Sponsor: Genmab | Conditions: Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm | Phase 1, Phase 2 | Status: TERMINATED